October 21, 2021
A number of methods currently exist to measure non-adherence and non-persistence of medical therapies, for improved...
Read article
October 7, 2021
‘Drugs do not work in patients who do not take them,’ said former surgeon general C. Everett Koop. Unfortunately, the...
Read article
April 28, 2021
Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,...
Read article
April 20, 2021
For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea...
Read article
April 13, 2021
There has been an increasing use of digital measures in drug development recently. New wearables technologies can help...
Read article
April 7, 2021
Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the...
Read article
March 31, 2021
As decentralized clinical trials become more attractive in an era of COVID-19, the role of wearables in clinical...
Read article
March 26, 2021
Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to...
Read article
March 19, 2021
The use of wearable and digital technology requires considerations for both drugs and devices regulations, and...
Read article
March 18, 2021
Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,...
Read article
March 12, 2021
With wearables likely to become a regular part of clinical trial design, statisticians could benefit by familiarizing...
Read article
March 11, 2021
In the recent years, Oncology trials are seeing a technological shift that is expected to make them faster and more...
Read article
March 9, 2021
When statistical sciences were in their infancy, the communicative benefits of statistics were widely touted. Thousands...
Read article
February 25, 2021
The convergence of several distinct trends has made wearables an increasingly attractive option for use in confirmatory...
Read article
February 19, 2021
C-Suite and R&D Decision-Makers are always striving to make evidence-driven decisions. Yet the rules by which evidence...
Read article
February 17, 2021
The COVID-19 Pandemic prompted the rapid surge in the generation of clinical data that has been scattered across...
Read article
February 11, 2021
The past two years have witnessed a heightened interest in the use of wearables in clinical development. The unexpected...
Read article
February 4, 2021
The past decade has witnessed the rise of simulations-based clinical trial optimization in a manner unimaginable to...
Read article
February 1, 2021
Cytel’s COVID-19 Trial Tracker continues to provide real time updates to the status of COVID-19 clinical trials...
Read article
January 29, 2021
Historically, advances in the statistical design of clinical trials have accompanied progress within the science and...
Read article
January 22, 2021
COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of...
Read article
January 11, 2021
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater...
Read article
December 21, 2020
2020 has been an unusually difficult year as the global pandemic impacted all of our lives. This year, the Cytel blog...
Read article
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
December 8, 2020
The Cytel COVID-19 Trial Tracker brings you an up to the minute, real time dashboard about COVID-19 trials around the...
Read article
December 1, 2020
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread. As...
Read article
November 24, 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR...
Read article
November 19, 2020
Data Monitoring Committees (DMCs) are groups of independent experts who periodically receive (by-arm) reports created...
Read article
November 12, 2020
Cytel and Ingress Health (now a Cytel company) will be contributing to a range of events at Virtual ISPOR EUROPE 2020,...
Read article
November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for...
Read article
November 3, 2020
When an expert statistician is paired with an experienced set of data managers, opportunities to capitalize on...
Read article
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel...
Read article
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his...
Read article
October 19, 2020
COVID-19 has created extreme uncertainties -- a dearth of historical information combined with the need for safety,...
Read article
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic...
Read article
October 13, 2020
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for...
Read article
October 7, 2020
With the rise in digital technologies, there has been an explosion in the volume and type of data sources. We can...
Read article
September 25, 2020
Regulators in both the United States and Europe have responded positively to the use of synthetic control arms (SCA)s...
Read article
September 16, 2020
Synthetic control arms (SCA) are virtual trial arms that use historical claims data and observational data to simulate...
Read article
June 22, 2020
Cytel scientists recently published a new eBook on synthetic control arms and a new scientific primer for the more...
Read article
June 8, 2020
Cytel has recently published a new ebook on synthetic control arms, and a new scientific primer as well.
Read article
May 12, 2020
In our previous blog, “Remote Working Arrangement – How to get it right?”, we talked about how the need for social...
Read article
March 5, 2020
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the...
Read article
February 20, 2020
It is widely acknowledged among drug developers that one of their most important assets is the data generated during...
Read article
January 30, 2020
The Cytel Trial Design Innovations (CTDI) Webinar Series recently hosted a webinar on designing event-based studies....
Read article
January 22, 2020
In the quest for clinical success, we all strive for evidence packages of the highest quality. If the clinical data is...
Read article
January 16, 2020
January’s Cytel Trial Design Innovations (CTDI) Webinar Series will feature Biostatistician and pioneering Bayesian...
Read article
January 8, 2020
In clinical development, data is the vital ‘foundation’ that supports your programs. To successfully bring a promising...
Read article
December 10, 2019
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September...
Read article
November 27, 2019
At the 2019 Challenges in Rare Diseases Clinical Trials Symposium and East training, Cytel partnered with Alexion to...
Read article
October 10, 2019
A disease is generally considered to be rare if it affects one patient per 200,000 people (1) and most rare diseases...
Read article
March 20, 2019
No one plans to have a trial whose data collection needs rescuing. However, lagging enrollment rates, operational...
Read article
January 10, 2019
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article
December 5, 2018
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...
Read article
November 27, 2018
This is the third in our blog series ' The Good Data Submission Doctor' in which Angelo Tinazzi, Director of Standards,...
Read article
November 5, 2018
Cytel biostatisticians Cyrus Mehta and Lingyun Liu, together with Charles Theuer, CEO of TRACON Pharmaceuticals have...
Read article
November 1, 2018
In this second post of the “Good Data Submission Doctor” ( read my first post The Master Recipe: Quality and Attention...
Read article
October 23, 2018
Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and...
Read article
September 20, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
September 5, 2018
EnForeSys is Cytel’s tool for patient recruitment planning. We have discussed on the blog recently with Tufts...
Read article
August 23, 2018
Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of...
Read article
July 27, 2018
In this blog, we share a new infographic based on this popular blog post illustrating some of the critical interactions...
Read article
July 24, 2018
At Cytel our strategic consulting team works on a wide range of projects including: Identifying the best clinical trial...
Read article
June 28, 2018
By Esha Senchaudhuri With thanks also to Jitendarreddy Seelam and Ramanatha Saralaya for their input. The fact of the...
Read article
June 19, 2018
At the recent PCMG conference in Malta, Adrian Otte ( Independent Consultant, formerly VP Global Development Operations...
Read article
June 14, 2018
In this blog, Paul Fardy, Executive Director of Data Management at Cytel shares his thoughts on how the data manager...
Read article
April 25, 2018
Data management is an essential building block for successful Immuno-Oncology (I-O) trials. At the Immuno-Oncology...
Read article
April 13, 2018
We return to our discussion with Ken Getz of the Tufts CSDD for part 2 of our blog post on key challenges in clinical...
Read article
April 5, 2018
Photo by J. Kelly Brito on Unsplash Research on clinical trial enrollment makes for sobering reading, characterized by...
Read article
March 16, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
February 21, 2018
By Diganta Bose, Statistical Programming Team Lead at Cytel Editor's note: This blog is based on work presented at...
Read article
February 13, 2018
Our strategic consulting team work on projects such as: Identifying the best clinical trial design, implementing...
Read article
February 6, 2018
We were excited to learn recently that Ajay Sathe, the CEO of our India Operations, was awarded lifetime honorary...
Read article
